248 related articles for article (PubMed ID: 23831329)
1. Inhibition of EGF signaling protects the diabetic retina from insulin-induced vascular leakage.
Sugimoto M; Cutler A; Shen B; Moss SE; Iyengar SK; Klein R; Folkman J; Anand-Apte B
Am J Pathol; 2013 Sep; 183(3):987-95. PubMed ID: 23831329
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Jun HO; Yu YS; Kim KW
Am J Pathol; 2010 Mar; 176(3):1517-24. PubMed ID: 20110406
[TBL] [Abstract][Full Text] [Related]
3. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
[TBL] [Abstract][Full Text] [Related]
4. Betacellulin induces increased retinal vascular permeability in mice.
Anand-Apte B; Ebrahem Q; Cutler A; Farage E; Sugimoto M; Hollyfield J; Folkman J
PLoS One; 2010 Oct; 5(10):e13444. PubMed ID: 20976146
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability.
Peters S; Cree IA; Alexander R; Turowski P; Ockrim Z; Patel J; Boyd SR; Joussen AM; Ziemssen F; Hykin PG; Moss SE
Cytokine; 2007 Nov; 40(2):144-50. PubMed ID: 17959386
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
Kim SR; Suh W
Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
[TBL] [Abstract][Full Text] [Related]
7. PKCζ mediates breakdown of outer blood-retinal barriers in diabetic retinopathy.
Omri S; Behar-Cohen F; Rothschild PR; Gélizé E; Jonet L; Jeanny JC; Omri B; Crisanti P
PLoS One; 2013; 8(11):e81600. PubMed ID: 24312324
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
9. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
[TBL] [Abstract][Full Text] [Related]
10. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
[TBL] [Abstract][Full Text] [Related]
12. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
13. Chrysin Ameliorates Malfunction of Retinoid Visual Cycle through Blocking Activation of AGE-RAGE-ER Stress in Glucose-Stimulated Retinal Pigment Epithelial Cells and Diabetic Eyes.
Kang MK; Lee EJ; Kim YH; Kim DY; Oh H; Kim SI; Kang YH
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30096827
[TBL] [Abstract][Full Text] [Related]
14. Significance of outer blood-retina barrier breakdown in diabetes and ischemia.
Xu HZ; Le YZ
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2160-4. PubMed ID: 21178141
[TBL] [Abstract][Full Text] [Related]
15. Apelin-13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI-3K/Akt and MAPK/Erk Signaling Pathways.
Li Y; Bai YJ; Jiang YR; Yu WZ; Shi X; Chen L; Feng J; Sun GB
Biomed Res Int; 2018; 2018():3242574. PubMed ID: 29850504
[TBL] [Abstract][Full Text] [Related]
16. δ Opioid Receptor Agonism Preserves the Retinal Pigmented Epithelial Cell Tight Junctions and Ameliorates the Retinopathy in Experimental Diabetes.
Lopes de Faria JM; Duarte DA; Simó R; García-Ramirez M; Dátilo MN; Pasqualetto FC; Lopes de Faria JB
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3842-3853. PubMed ID: 31529081
[TBL] [Abstract][Full Text] [Related]
17. Endogenous insulin signaling in the RPE contributes to the maintenance of rod photoreceptor function in diabetes.
Tarchick MJ; Cutler AH; Trobenter TD; Kozlowski MR; Makowski ER; Holoman N; Shao J; Shen B; Anand-Apte B; Samuels IS
Exp Eye Res; 2019 Mar; 180():63-74. PubMed ID: 30543793
[TBL] [Abstract][Full Text] [Related]
18. Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.
Li J; Wang JJ; Chen D; Mott R; Yu Q; Ma JX; Zhang SX
Exp Eye Res; 2009 Jun; 89(1):71-8. PubMed ID: 19254713
[TBL] [Abstract][Full Text] [Related]
19. Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy.
Rudraraju M; Narayanan SP; Somanath PR
Pharmacol Res; 2020 Nov; 161():105115. PubMed ID: 32750417
[TBL] [Abstract][Full Text] [Related]
20. Human plasminogen-derived N-acetyl-Arg-Leu-Tyr-Glu antagonizes VEGFR-2 to prevent blood-retinal barrier breakdown in diabetic mice.
Park W; Kim J; Choi S; Kim T; Park M; Kim S; You JC; Kim JH; Ha KS; Lee JH; Kwon YG; Kim YM
Biomed Pharmacother; 2021 Feb; 134():111110. PubMed ID: 33338749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
